 |
Corporate News
30-Nov-22
|
|
|
|
|
|
|
|
|
|
|
|
J B Chemical receives USFDA approval for Venlafaxine Extended Release Tablets
|
|
|
|
|
|
|
|
J B Chemicals & Pharmaceuticals has received ANDA approval from the USFDA for Venlafaxine Extended Release Tablets 37.5mg, 75mg, 150mg and 225mg. This product is based on OROS (Osmotic Controlled Release Oral Delivery System) technology, an advanced and precision-controlled release mechanism. The generic product approval is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Venlafaxine Hydrochloride Extended-Release Tablets, 37.5 mg, 75 mg, 150 mg, and
225 mg, of Osmotica Pharmaceutical U.S. LLC.
As per IQVIA Health MAT Oct 2022 data, Venlafaxine Extended-Release tablets recorded annualized sales of approximately $ 48 million in the US.
|
|
|
|
Previous News |
J B Chemicals & Pharmaceuticals to discuss results
(
Corporate News
-
27-Jul-22
11:54
)
|
|
|
J B Chemicals & Pharmaceuticals allots 10,210 equity shares under ESOS
(
Corporate News
-
30-Nov-23
10:34
)
|
|
|
J B Chemicals & Pharmaceuticals allots 11,582 equity shares under ESOS
(
Corporate News
-
04-Jun-24
19:00
)
|
|
|
Board of J B Chemicals & Pharmaceuticals recommends appointment of director
(
Corporate News
-
03-Jun-24
13:32
)
|
|
|
Board of J B Chemicals & Pharmaceuticals recommends final dividend
(
Corporate News
-
27-May-23
17:59
)
|
|
|
J B Chemicals & Pharmaceuticals to convene board meeting
(
Corporate News
-
02-Aug-23
16:51
)
|
|
|
J B Chemicals & Pharmaceuticals CFO resigns
(
Corporate News
-
07-Sep-23
18:22
)
|
|
|
J B Chemicals & Pharmaceuticals allots 5,320 equity shares under ESOS
(
Corporate News
-
13-Sep-22
17:37
)
|
|
|
Board of J B Chemicals & Pharmaceuticals recommends final dividend
(
Corporate News
-
27-May-22
14:06
)
|
|
|
J B Chemical rises after Q4 PAT jumps 101% YoY
(
Hot Pursuit
-
15-Jun-21
09:54
)
|
|
|
J B Chemicals & Pharmaceuticals Ltd Surges 4.41%
(
Hot Pursuit
-
17-Sep-20
09:30
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|